HRES 308 dismisses an election contest for Florida's 14th Congressional District Representative, filed on November 17, 2024. The resolution states the House lacks jurisdiction over primary election disputes under federal law (2 U.S.C. 381(1)), as the contest involved a primary election rather than a general election. This formal dismissal ends the specific legal challenge without altering election laws or outcomes. The decision means the House will not review the dispute, and the election results stand as certified by state authorities.
HRES 311 dismisses an election contest for Texas's 30th Congressional District Representative due to untimely filing with the House. This procedural resolution directly ends a legal challenge to the election outcome without addressing the merits of the contest. The bill formally closes the matter based solely on the filing deadline being missed, as stated in the resolution text. It affects no broader policy or constituency, only resolving the specific election dispute. The House Committee on House Administration reported this resolution on April 9, 2025.
HRES 309 dismisses an election contest for Texas's 28th Congressional District Representative due to untimely filing with the House. The resolution ends the legal challenge regarding the election result without changing who currently holds the seat. It directly affects the specific election contest in question but has no broader policy impact. This is a procedural action, not a substantive legislative change.
This House Resolution (HRES 312) dismisses an election contest for Florida's 14th Congressional District. It specifically ends a challenge filed on January 9, 2025, regarding the election for that district's representative. The resolution states the contest was dismissed due to being filed after the required deadline. This is a procedural action with no new policy or funding impact.
HRES 310 dismisses a legal challenge to the election for Alaska's at-large congressional seat. The resolution states the House lacks jurisdiction under federal law to review primary elections, as defined by the Federal Contested Election Act (2 U.S.C. 381(1)). This means the contest - likely concerning a primary election or party event - cannot proceed before the House. The dismissal directly ends the legal challenge without further House action. Consequently, the election results for Alaska's congressional district will stand without House review.
This bill directs the American Battle Monuments Commission to correct historical errors by identifying Jewish World War I and II veterans buried overseas under incorrect Christian markers (Latin crosses) and replacing them with appropriate markers. It establishes a 10-year program to contact families of affected veterans, with the Commission funding the effort at $500,000 annually through nonprofit contracts. The program specifically targets veterans buried in foreign U.S. military cemeteries with markers indicating non-Jewish faith, addressing a documented mistake affecting approximately 900 Jewish servicemembers. This directly affects Jewish veterans' families by honoring their heritage and correcting past burial inaccuracies.
HR 4305, the DUMP Red Tape Act, creates a Small Business Administration hotline for small businesses to report regulatory burdens they face when complying with federal agency rules. Small businesses (as defined by the Small Business Act) can submit complaints via email, website, or phone through this hotline, which must be established within 180 days of the bill's enactment. The Chief Counsel for Advocacy must then submit annual reports to Congress detailing the most frequently reported rules, affected industries, geographic data, and recommendations for agencies to address these burdens. This bill establishes a reporting mechanism but does not directly change existing regulations.
This bill requires IRS employees to obtain written approval from a supervisor before sending any penalty notice to a taxpayer. It modifies the Internal Revenue Code to mandate that an IRS official’s immediate supervisor (the person they report to) must personally approve penalty assessments in writing before any penalty communication is sent. The rule applies to all penalties issued after December 31, 2025. This directly affects taxpayers who face IRS penalty notices, adding a review step before penalties are formally proposed or imposed.
HR 4549, the Office of Rural Affairs Enhancement Act, amends the Small Business Administration's structure to better serve rural small businesses. It requires the Office's Assistant Administrator to have specific rural business expertise and mandates new outreach activities, including regional webinars and events for rural small business owners. The bill also adds annual reporting requirements for the SBA, detailing the Office's budget, staff, outreach events, and analysis of lending programs targeting rural businesses. These changes directly affect rural small business concerns (defined as those in rural areas per SBA rules) and the SBA's operational approach to their support. The legislation focuses on strengthening the Office's capacity to connect rural businesses with federal resources.
This bill reduces the required aggregate market value of voting and non-voting common equity shares for an issuer of securities to qualify as a well-known seasoned issuer. A well-known seasoned issuer is allowed to make expedited public offerings of securities through automatic shelf registrations.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
This bill denies immigration benefits to individuals who participated in, supported, or facilitated Hamas attacks against Israel starting October 7, 2023. It amends immigration law to make such individuals inadmissible (barred from entering the U.S.) and ineligible for any immigration relief, including asylum or other protections. The law requires annual reports from the Homeland Security Secretary tracking how many people are denied entry or removed under these provisions. It directly affects non-U.S. nationals involved in Hamas-related violence against Israel since the October 7, 2023, attacks.
